Coupling of vascular CaV1.2 channels in health and disease

血管 CaV1.2 通道在健康和疾病中的耦合

基本信息

  • 批准号:
    10306953
  • 负责人:
  • 金额:
    $ 57.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Abstract . How a given protein organizes into a functional complex in health and disease is particularly relevant for membrane proteins that serve as key information entry points for cells. A suitable and highly relevant example is voltage-gated L-type CaV1.2 channels, which play a major role in arterial myocyte function and vascular reactivity. These channels have been shown to gate in unison (i.e. cooperative gating) to amplify Ca2+ influx. At present, however, a comprehensive understanding of mechanisms fostering the induction of CaV1.2 cooperative gating as well as its functional implications in health and disease represent major knowledge gaps. The overall objective of this proposal is to investigate the requirement and physiological consequences whereby phosphorylation of a single amino acid – S1928 – in the C-terminal of vascular CaV1.2 channels promotes dynamic spatial organization of CaV1.2 to facilitate cooperative gating at the surface membrane. To accomplish this goal, we are testing the central hypothesis that CaV1.2 S1928 phosphorylation tunes dynamic channel clustering and cooperative gating, and that this contributes to modulate vascular function in response to elevated extracellular glucose and during diabetes. This hypothesis is formulated on the basis of strong and rigorous preliminary data revealing an unanticipated and remarkable role for S1928 phosphorylation as the culprit for redistribution and assembly of CaV1.2 subunits into superclusters at the surface membrane of arterial myocytes upon elevated glucose and diabetes. CaV1.2 superclusters mediated by S1928 phosphorylation promotes CaV1.2 cooperative gating and Ca2+ influx amplification into arterial myocytes. Key findings that further underscore the significance of our observations is that CaV1.2 S1928 phosphorylation is necessary for activation of prohypertensive signaling pathways, vasoconstriction and altered blood flow upon elevated glucose and during diabetes. Moreover, critical observations have been validated in freshly dissociated human arterial myocytes from nondiabetic and diabetic patients, underscoring the translational relevance. Emerging and innovative concepts that will be explored in this application are the role of S1928 phosphorylation as 1) a rheostat of CaV1.2 function and vascular reactivity and 2) a major risk factor for vascular complications in diabetes. A multiscale contemporary approach that includes innovative microscopy techniques, sophisticated biochemistry, electrophysiology, in silico analysis and unique animal models will be implemented to explore the following aims. Aim 1 is to elucidate the role of S1928 phosphorylation in dynamic CaV1.2 clustering and cooperative gating upon elevated glucose. Aim 2 is to examine the requirement of S1928 phosphorylation to induce CaV1.2 superclustering and cooperative gating in arterial myocytes during diabetes. Results will transform our understanding of how CaV1.2 are organized in arterial myocytes (and perhaps other cells) in health and disease and may lay the foundation for novel therapeutic strategies with single amino acid accuracy to correct channel function and vascular reactivity.
抽象。 给定的蛋白质如何组织成健康和疾病中的功能复合物, 作为细胞关键信息入口的膜蛋白。一个合适且高度相关的例子 是电压门控L型CaV1.2通道,其在动脉肌细胞功能和血管内皮功能中起主要作用。 反应性这些通道已被证明是门控一致(即合作门控),以放大Ca 2+流入。在 目前,然而,促进CaV1.2合作诱导机制的全面理解, 门控及其在健康和疾病方面的功能影响是主要的知识差距。整体 本建议的目的是调查的要求和生理后果, 血管CaV1.2通道C末端的单个氨基酸- S1928 -的磷酸化促进 CaV1.2的动态空间组织,以促进表面膜的合作门控。完成 为此,我们正在验证CaV1.2 S1928磷酸化调节动态通道的中心假设, 聚集和合作门控,并且这有助于调节血管功能以响应升高的 细胞外葡萄糖和糖尿病期间。这一假设是建立在强有力的和严格的 初步数据揭示了S1928磷酸化作为导致癌症的罪魁祸首的意想不到的和显著的作用。 CaV 1.2亚单位在动脉肌细胞表面膜上的再分布和组装成超簇 血糖升高和糖尿病由S1928磷酸化介导的CaV1.2超簇促进 CaV1.2协同门控和Ca 2+内流放大进入动脉肌细胞。关键发现进一步 强调我们观察结果的重要性是CaV1.2 S1928磷酸化对于 葡萄糖升高时促高血压信号通路的激活、血管收缩和血流改变 在糖尿病期间。此外,在新鲜分离的人动脉中已经验证了关键观察结果。 来自非糖尿病和糖尿病患者的肌细胞,强调了翻译相关性。新兴和 在本申请中将探索的创新概念是S1928磷酸化的作用:1)a CaV1.2功能和血管反应性的变阻器和2)血管并发症的主要危险因素, 糖尿病一种多尺度的当代方法,包括创新的显微技术,复杂的 生物化学,电生理学,计算机分析和独特的动物模型将被实施,以探索 的目标。目的1是阐明S1928磷酸化在动态CaV1.2聚集中的作用, 葡萄糖升高时的协同门控。目的2是检查S1928磷酸化对细胞增殖的需要。 糖尿病期间动脉肌细胞CaV1.2超聚集和协同门控诱导结果将改变 我们对CaV1.2如何在健康的动脉肌细胞(也许还有其他细胞)中组织的理解, 疾病,并可能奠定了基础,为新的治疗策略与单一氨基酸的准确性,以纠正 通道功能和血管反应性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Manuel F Navedo其他文献

Manuel F Navedo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Manuel F Navedo', 18)}}的其他基金

Regulation of a cardiac b1AR/SERCA2 complex in heart failure
心力衰竭中心脏 b1AR/SERCA2 复合物的调节
  • 批准号:
    10641923
  • 财政年份:
    2022
  • 资助金额:
    $ 57.91万
  • 项目类别:
Regulation of a cardiac b1AR/SERCA2 complex in heart failure
心力衰竭中心脏 b1AR/SERCA2 复合物的调节
  • 批准号:
    10539066
  • 财政年份:
    2022
  • 资助金额:
    $ 57.91万
  • 项目类别:
cAMP signaling in vascular smooth muscle in health and disease
健康和疾病状态下血管平滑肌中的 cAMP 信号传导
  • 批准号:
    10370716
  • 财政年份:
    2021
  • 资助金额:
    $ 57.91万
  • 项目类别:
cAMP signaling in vascular smooth muscle in health and disease
健康和疾病状态下血管平滑肌中的 cAMP 信号传导
  • 批准号:
    10532163
  • 财政年份:
    2021
  • 资助金额:
    $ 57.91万
  • 项目类别:
A single amino acid in CaV1.2 controls channel activity and arterial tone in hypertension
CaV1.2 中的单个氨基酸控制高血压中的通道活性和动脉张力
  • 批准号:
    10392387
  • 财政年份:
    2019
  • 资助金额:
    $ 57.91万
  • 项目类别:
Cerebral Vascular Smooth Muscle Dysfunction in Alzheimer's Disease
阿尔茨海默氏病的脑血管平滑肌功能障碍
  • 批准号:
    10488479
  • 财政年份:
    2019
  • 资助金额:
    $ 57.91万
  • 项目类别:
Coupling of Vascular Cav1.2 Channels In Health & Disease
健康中血管 Cav1.2 通道的耦合
  • 批准号:
    8960054
  • 财政年份:
    2015
  • 资助金额:
    $ 57.91万
  • 项目类别:
Coupling of vascular CaV1.2 channels in health and disease
血管 CaV1.2 通道在健康和疾病中的耦合
  • 批准号:
    10613545
  • 财政年份:
    2015
  • 资助金额:
    $ 57.91万
  • 项目类别:
Coupling of vascular CaV1.2 channels in health and disease
血管 CaV1.2 通道在健康和疾病中的耦合
  • 批准号:
    10451644
  • 财政年份:
    2015
  • 资助金额:
    $ 57.91万
  • 项目类别:
Calcium sparklets-induced vascular dysfunction during diabetes
糖尿病期间钙火花诱导的血管功能障碍
  • 批准号:
    7982925
  • 财政年份:
    2010
  • 资助金额:
    $ 57.91万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.91万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 57.91万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.91万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.91万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.91万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.91万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.91万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 57.91万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 57.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 57.91万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了